Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
River Eletec
6666
Forside
2330
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -32.36%17.5B | 20.10%63.55B | -84.68%4.02B | 180.43%21.76B | -72.35%11.9B | 142.08%25.88B | 618.43%52.92B | 241.96%26.26B | -449.18%-27.05B | 790.02%43.02B |
Net profit before non-cash adjustment | -39.05%11.87B | 13.95%66.26B | 0.71%16.09B | -23.78%13.15B | 32.89%17.55B | 66.23%19.48B | 56.82%58.15B | 46.35%15.97B | 93.54%17.26B | 57.00%13.2B |
Total adjustment of non-cash items | -51.35%9.39B | 146.27%6.97B | 47.11%-6.98B | 93.87%-735M | -211.70%-4.62B | 222.31%19.3B | -314.73%-15.06B | -1,530.53%-13.19B | -505.34%-11.99B | -15.50%4.14B |
-Depreciation and amortization | 4.71%911M | 4.38%3.62B | 0.63%965M | 2.05%896M | 0.11%889M | 17.09%870M | 23.68%3.47B | 20.93%959M | 44.17%878M | 33.73%888M |
-Share of associates | 100.00%4M | -240.96%-351M | -213.33%-323M | 13.64%-19M | 0.00%-11M | 166.67%2M | -69.18%249M | 2,135.71%285M | -102.89%-22M | -136.67%-11M |
-Disposal profit | --4M | 50.04%-638M | 3,056.00%789M | -612.41%-1.03B | 39.66%-394M | --0 | -544.95%-1.28B | --25M | -149.15%-145M | -8,062.50%-653M |
-Net exchange gains and losses | 35.18%-398M | -73.17%-1.02B | 5.87%-321M | 161.93%135M | -454.84%-220M | -567.39%-614M | -636.25%-589M | -298.26%-341M | -1,576.92%-218M | 165.96%62M |
-Other non-cash items | -53.43%8.87B | 131.68%5.36B | 42.72%-8.09B | 94.28%-714M | -226.84%-4.89B | 225.84%19.04B | -629.64%-16.91B | -702.22%-14.12B | -1,055.82%-12.48B | -10.52%3.85B |
Changes in working capital | 70.84%-3.76B | -198.46%-9.68B | -121.65%-5.08B | 128.90%9.34B | -104.02%-1.03B | -83.85%-12.9B | 118.10%9.83B | 182.09%23.48B | -682.49%-32.32B | 231.41%25.68B |
-Change in receivables | 220.17%3.44B | 156.50%23.19B | 1,041.86%17.68B | 194.66%24.74B | -18.63%-16.36B | -7.12%-2.86B | -77.22%-41.05B | 143.94%1.55B | -711.43%-26.14B | 0.40%-13.79B |
-Change in inventory | -2,127.44%-11.82B | 121.13%16.03B | 148.16%12.07B | 105.25%1.05B | 116.75%2.34B | 103.43%583M | -77.39%-75.88B | -6.58%-25.05B | -28.91%-19.89B | -137.05%-13.96B |
-Change in payables | 143.50%4.62B | -138.58%-48.9B | -174.12%-34.83B | -219.96%-16.44B | -75.68%12.99B | -184.13%-10.62B | 989.22%126.75B | 3,079.33%46.98B | -5.59%13.71B | 26,886.36%53.43B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 41.26%-400M | -1.11%-1.91B | 57.76%-313M | 28.19%-400M | -28.89%-513M | -258.42%-681M | -473.25%-1.89B | -626.47%-741M | -614.10%-557M | -485.29%-398M |
Interest received (cash flow from operating activities) | 205.45%168M | 29.88%526M | 29.60%289M | -15.09%45M | 82.67%137M | 1.85%55M | 87.50%405M | 38.51%223M | 278.57%53M | 167.86%75M |
Tax refund paid | 30.89%-8.32B | -77.23%-22.22B | 31.37%-1.06B | -119.85%-7.12B | -41.58%-2B | -89.83%-12.04B | -140.53%-12.54B | -53.08%-1.54B | -178.59%-3.24B | -51.07%-1.41B |
Other operating cash inflow (outflow) | 0 | 0 | 0.00%1M | 0 | -200.00%-1M | 0 | 0 | 200.00%1M | -1M | 0.00%1M |
Operating cash flow | -32.26%8.95B | 2.71%39.95B | -87.84%2.94B | 146.36%14.28B | -76.95%9.52B | 213.77%13.21B | 350.39%38.9B | 224.43%24.2B | -572.33%-30.8B | 672.62%41.28B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 13.67%-341M | -36.68%-1.36B | -3.06%-236M | -31.98%-326M | -263.06%-403M | 3.19%-395M | -6.65%-995M | -30.11%-229M | -61.44%-247M | 43.94%-111M |
Net intangibles purchase and sale | -95.54%-307M | 21.70%-902M | -41.80%-346M | 12.61%-194M | 35.53%-205M | 57.34%-157M | 56.03%-1.15B | 44.42%-244M | 67.01%-222M | 60.20%-318M |
Net business purchase and sale | 81.34%-172M | ---14.63B | ---13.98B | --485M | ---211M | ---922M | --0 | --0 | --0 | --0 |
Net investment product transactions | 61.04%-30M | -135.30%-437M | 143.53%138M | -112.03%-228M | 18.43%-270M | -755.56%-77M | 2,576.00%1.24B | -1,168.00%-317M | --1.9B | -2,658.33%-331M |
Advance cash and loans provided to other parties | -363.30%-505M | -141.12%-1.72B | -277.88%-786M | -62.42%-268M | ---561M | 68.13%-109M | -122.05%-715M | ---208M | -22.22%-165M | --0 |
Repayment of advance payments to other parties and cash income from loans | 156.44%418M | -5.72%626M | -30.29%145M | -18.52%110M | --208M | -49.22%163M | 40.08%664M | --208M | 5.47%135M | --0 |
Net changes in other investments | 86.67%-4M | -138.46%-35M | -288.89%-17M | -136.36%-4M | -84.00%16M | -3.45%-30M | 1,720.00%91M | -40.00%9M | 184.62%11M | 809.09%100M |
Investing cash flow | 38.38%-941M | -2,023.94%-18.46B | -1,830.73%-15.08B | -130.21%-425M | -116.06%-1.43B | -82.87%-1.53B | 47.43%-869M | -24.96%-781M | 266.31%1.41B | 34.33%-660M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 176.29%9.28B | 16.26%-5.78B | 476.83%26.3B | -188.67%-11.1B | 32.07%-8.81B | -2,444.89%-12.17B | -134.15%-6.91B | -135.57%-6.98B | 2,991.92%12.52B | -381.45%-12.97B |
Net common stock issuance | 0.00%-1M | 16.71%-4.97B | -344.44%-5B | 100.56%27M | --0 | ---1M | -10,577.19%-5.97B | ---1.13B | -8,603.51%-4.85B | --0 |
Cash dividends paid | -58.20%-7.02B | -20.60%-9.39B | 86.05%-12M | -21.92%-4.83B | -26.92%-99M | -21.54%-4.44B | -92.48%-7.78B | -62.26%-86M | -62.83%-3.97B | -110.81%-78M |
Cash dividends for minorities | --0 | -17.44%-1.12B | --0 | --0 | ---- | ---- | -83.08%-952M | --0 | --0 | ---- |
Net other fund-raising expenses | -24.57%-218M | 68.05%-1.75B | -252.99%-358M | 21.10%-1.05B | 95.94%-173M | -31.58%-175M | -305.24%-5.49B | 122.85%234M | -1,084.82%-1.33B | -2,779.05%-4.26B |
Financing cash flow | 112.16%2.04B | 15.08%-23.01B | 363.06%20.93B | -811.58%-16.96B | 44.14%-10.2B | -413.80%-16.79B | -288.61%-27.1B | -142.90%-7.96B | 181.53%2.38B | -567.85%-18.26B |
Net cash flow | ||||||||||
Beginning cash position | 3.02%38.62B | 49.38%37.49B | 32.82%28.79B | -34.47%32.7B | 27.29%34.69B | 49.38%37.49B | -1.33%25.1B | -14.06%21.67B | 130.02%49.9B | 5.19%27.25B |
Current changes in cash | 297.08%10.05B | -113.93%-1.52B | -43.15%8.79B | 88.51%-3.1B | -109.44%-2.11B | -4,778.90%-5.1B | 487.62%10.93B | 1,110.72%15.46B | -1,081.68%-27.01B | 618.67%22.36B |
Effect of exchange rate changes | -5.32%2.17B | 80.91%2.65B | 194.10%1.05B | 33.61%-808M | -57.84%121M | 12.40%2.29B | -37.65%1.47B | -74.77%356M | -259.92%-1.22B | 187.00%287M |
Cash adjustments other than cash changes | --2M | 0.00%-1M | ---- | ---- | ---- | ---- | -100.79%-1M | ---- | ---- | ---- |
End cash Position | 46.60%50.85B | 3.02%38.62B | 3.02%38.62B | 32.82%28.79B | -34.47%32.7B | 27.29%34.69B | 49.38%37.49B | 49.38%37.49B | -14.06%21.67B | 130.02%49.9B |
Free cash flow | -34.48%8.29B | 2.53%37.68B | -90.06%2.36B | 144.00%13.76B | -78.21%8.9B | 268.64%12.66B | 292.50%36.75B | 218.26%23.73B | -649.38%-31.27B | 597.82%40.85B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |